Chinese Medicine Net

FDA and Tongjitang’s (NYSE:TCM) Osteoporosis Drug Xianling Gubao

Sunday, February 17th, 2008

 Tongjitang Pharmaceuticals (NYSE:TCM) announced its mainstay traditional Chinese medicine for osteoporosis, Xianling Gubao, was effective in a two-year trial. The randomized, double-blind, multi-center study demonstrated that Xianling Gubao prevented bone resorption and increased bone density. The trial was conducted in patients with post-menopausal osteoporosis. Bone resorption is the process by which osteoclasts ...

Posted in China, Diseases & Conditions, News, Osteoporosis, stock | No Comments »

Tongjitang Chinese Medicines Co. TCM (NYSE)

Wednesday, November 21st, 2007

Tongjitang Chinese Medicines Company (Tongjitang), incorporated on May 16, 2006, is a vertically integrated and specialty pharmaceutical company focusing on the development, manufacturing and marketing of Chinese medicine. The Company's principal product, Xianling Gubao, is a Chinese medicine for the treatment of osteoporosis in China.

Posted in China, Diseases & Conditions, News, Osteoporosis, World, stock | No Comments »